Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “asthma”

A Study of CDX-622 in Participants With Mild to Moderate AsthmaRecruiting
NCT07330778Phase 1Updated Jul 2, 2026
Sponsor: Celldex Therapeutics
Mild to Moderate Asthma
United States
Depemokimab Asthma Imaging and Bronchoscopy Sub-StudyRecruiting
NCT06979323Phase 3Updated Jul 2, 2026
Sponsor: GlaxoSmithKline
Asthma
United States, Belgium, Canada, China, France +7 more
Treating Exacerbations of Asthma With Oral Montelukast in ChildrenCompleted
NCT05819541Phase 2Updated Jul 2, 2026
Sponsor: Vanderbilt University Medical Center
Status Asthmaticus
United States
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)Completed
NCT04609904Phase 3Updated Jul 2, 2026
Sponsor: AstraZeneca
Asthma
United States, Brazil, China, Colombia, Czechia +11 more
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaActive Not Recruiting
NCT06676319Phase 2Updated Jul 1, 2026
Sponsor: Sanofi
Asthma
United States, Argentina, Belgium, Brazil, Canada +17 more
The Impact of Anxiety/Depression on the Efficacy of Asthma Control Drugs and the Construction of a Predictive Model for the Risk of Acute Asthma AttacksRecruiting
NCT07679321N/AUpdated Jul 1, 2026
Sponsor: Xiangya Hospital of Central South University
Anxiety/Depression and Asthma
China
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung DiseaseRecruiting
NCT06985225N/AUpdated Jul 1, 2026
Sponsor: University of Kansas Medical Center
Severe Asthma · COPD · Non-CF Bronchiectasis · Cystic Fibrosis (CF)
United States
Protocol CAUSE-03 / CHEETAHRecruiting
NCT06136091N/AUpdated Jul 1, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Asthma
United States
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)Completed
NCT04699604Phase 3Updated Jul 1, 2026
Sponsor: Bridgette Jones
Allergic Asthma
United States
Quantifying the Burden of Type 2 (T2) Inflammation in AsthmaNot Yet Recruiting
NCT07675044N/AUpdated Jun 30, 2026
Sponsor: Icahn School of Medicine at Mount Sinai
Asthma · Type 2 Asthma
United States
A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma StudyRecruiting
NCT07677059Phase 2Updated Jun 30, 2026
Sponsor: Kymera Therapeutics, Inc.
Asthma (Diagnosis)
United States
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)Completed
NCT04609878Phase 3Updated Jun 30, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, Belgium, Bulgaria, Canada +16 more
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller MedicationTerminated
NCT01875003Phase 3Updated Jun 30, 2026
Sponsor: Hoffmann-La Roche
Asthma
United States, Argentina, Brazil, Canada, Colombia +16 more
The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx StudyCompleted
NCT06666504N/AUpdated Jun 29, 2026
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Severe Asthma
United Kingdom
Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in AdolescentsCompleted
NCT04748055N/AUpdated Jun 29, 2026
Sponsor: University of North Carolina, Chapel Hill
Asthma
United States
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate AsthmaRecruiting
NCT07660731Phase 1Updated Jun 29, 2026
Sponsor: Pfizer
Healthy Volunteer Study · Healthy Adults · Healthy Participants · Asthma
United States
Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish PracticeRecruiting
NCT07651891Phase 4Updated Jun 29, 2026
Sponsor: Karolinska Institutet
Allergic Rhinitis · Asthma (Diagnosis)
Sweden
A Study of Depemokimab in Participants of 6 to 11 Years of AgeNot Yet Recruiting
NCT07671001Phase 3Updated Jun 26, 2026
Sponsor: GlaxoSmithKline
Asthma
TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)Completed
NCT02676089Phase 3Updated Jun 26, 2026
Sponsor: Chiesi Farmaceutici S.p.A.
Asthma
Argentina, Belarus, Bulgaria, Czechia, Germany +12 more
Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple TherapyRecruiting
NCT07030881NAUpdated Jun 26, 2026
Sponsor: First Affiliated Hospital of Ningbo University
Asthma, COPD
China
TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)Active Not Recruiting
NCT05729711N/AUpdated Jun 26, 2026
Sponsor: AstraZeneca
Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)
Japan
Medication Adherence With Telehealthcare Medication Therapy ManagementCompleted
NCT03978936NAUpdated Jun 26, 2026
Sponsor: Johns Hopkins University
Uncontrolled Asthma · Young Adults
United States
TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABACompleted
NCT02676076Phase 3Updated Jun 26, 2026
Sponsor: Chiesi Farmaceutici S.p.A.
Asthma
Germany
Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus ChallengeRecruiting
NCT07059767Phase 2Updated Jun 26, 2026
Sponsor: Ethris GmbH
Asthma (Diagnosis)
United Kingdom
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate AsthmaRecruiting
NCT07301736Phase 2Updated Jun 25, 2026
Sponsor: Chiesi Farmaceutici S.p.A.
Asthma
Argentina, Bosnia and Herzegovina, Bulgaria, Czechia, Germany +9 more

Previous page Next page